Google+ Badge

Wednesday, July 1, 2015

Cardiovascular Research: Clot-removal devices now recommended for some stroke patients ♦ Platelet-like particles boost clotting, slow bleeding

Having a stroke? Where you are makes a huge difference in your treatment It looks like a crazy quilt spread over the continent. But a new map of emergency stroke care in America shows just how much of a patchwork system we still have for delivering the most effective stroke treatment. And thousands of people a year may end up unnecessarily disabled as a result.
Clot-removal devices now recommended for some stroke patients Updated stroke treatment recommendations include using a stent retrieval device to remove blood clots from large arteries in select patients. Clot-busting medication -- tPA -- continues to be the gold standard for treating clot-caused stroke. Clot busters and/or clot-removal procedures must be administered within a few hours of stroke symptoms, so everyone needs to know to call 9-1-1 and seek immediate help if they occur.
Recommendations for left atrial appendage occlusion Experts have released a new overview on the implantation of left atrial appendage occlusion devices. The implantation of left atrial appendage occlusion devices may lower the risk of stroke in patients with atrial fibrillation, researchers note
Cardiac survival rates around 6 percent for those occurring outside of a hospital Cardiac arrest strikes almost 600,000 people each year, killing the vast majority of those individuals, says a new report. Following a cardiac arrest, each minute without treatment decreases the likelihood of surviving without disability, and survival rates depend greatly on where the cardiac arrest occurs, said the committee that carried out the study and wrote the report.
Platelet-like particles boost clotting, slow bleeding Tiny gel particles that can perform the same essential functions as platelets have been developed by researchers. The particles could one day be used to control excessive bleeding following traumatic injury or in individuals with impaired clotting due to an inherited condition or as a result of certain medications or chemotherapy.

No comments:

Post a Comment